Goodwin Procter advised Meletios Therapeutics on the deal. Meletios Therapeutics, a French biotechnology company specialized in the research and development of next-generation antiviral treatments, announced a...
Goodwin Procter advised Meletios Therapeutics on the deal. Meletios Therapeutics, a French biotechnology company specialized in the research and development of next-generation antiviral treatments, announced a...
